Targeting the sarcomere to correct muscle function

PM Hwang, BD Sykes - Nature reviews Drug discovery, 2015 - nature.com
Various human diseases can disrupt the balance between muscle contraction and
relaxation. Sarcomeric modulators can be used to readjust this balance either indirectly by …

Chronic wound repair and healing in older adults: current status and future research

L Gould, P Abadir, H Brem, M Carter… - Wound Repair and …, 2015 - Wiley Online Library
The incidence of chronic wounds is increased among older adults, and the impact of chronic
wounds on quality of life is particularly profound in this population. It is well established that …

The rat as an animal model in chronic wound research: An update

M Ghanbari, Y Salkovskiy, MA Carlson - Life Sciences, 2024 - Elsevier
The increasing global prevalence of chronic wounds underscores the growing importance of
developing effective animal models for their study. This review offers a critical evaluation of …

Evaluation of cell therapy on exercise performance and limb perfusion in peripheral artery disease: the CCTRN PACE trial (patients with intermittent claudication …

EC Perin, MP Murphy, KL March, R Bolli, J Loughran… - Circulation, 2017 - Am Heart Assoc
Background: Atherosclerotic peripheral artery disease affects 8% to 12% of Americans> 65
years of age and is associated with a major decline in functional status, increased …

Applications of in vivo functional testing of the rat tibialis anterior for evaluating tissue engineered skeletal muscle repair

EL Mintz, JA Passipieri, DY Lovell… - Journal of visualized …, 2016 - pmc.ncbi.nlm.nih.gov
Despite the regenerative capacity of skeletal muscle, permanent functional and/or cosmetic
deficits (eg, volumetric muscle loss (VML) resulting from traumatic injury, disease and …

[HTML][HTML] Post-stroke treatment with K-134, a phosphodiesterase 3 inhibitor, improves stroke outcomes in the stroke-prone spontaneously hypertensive rat model–A …

H Yoshida, S Itoh, F Ferdousi, H Isoda - Journal of Pharmacological …, 2022 - Elsevier
Post-stroke antiplatelet therapy has been proved to reduce the risk of recurrent stroke;
however, it may also increase the incidence of intracranial hemorrhage that could offset any …

K-134, a phosphodiesterase 3 inhibitor, prevents brain damage by inhibiting thrombus formation in a rat cerebral infarction model

H Yoshida, Y Ashikawa, S Itoh, T Nakagawa… - 2012 - journals.plos.org
Background K-134 is a more potent antiplatelet drug with a selective inhibitory effect on
phosphodiesterase 3 (PDE3) compared with its analogue, cilostazol. Objectives This study …

Prasugrel, a Platelet P2Y12 Receptor Antagonist, Improves Abnormal Gait in a Novel Murine Model of Thrombotic Hindlimb Ischemia

K Ohno, A Tomizawa, M Mizuno… - Journal of the …, 2016 - Am Heart Assoc
Background The efficacy of P2Y12 inhibition for the prevention of cardiovascular events in
patients with peripheral arterial disease (PAD) has been established. However, the …

K-134, a phosphodiesterase 3 inhibitor, improves gait disturbance and hindlimb blood flow impairment in rat peripheral artery disease models

Y Sasaki, H Suzuki, S Itoh, H Yoshida, S Kondo… - European journal of …, 2012 - Elsevier
K-134, a phosphodiesterase 3 (PDE3) inhibitor with anti-thrombotic and anti-hyperplastic
activity, is being developed for the treatment of intermittent claudication. We assessed the …

[HTML][HTML] Effect of inducible co-stimulatory molecule siRNA in cerebral infarction rat models

Y Luo, Y Yang, H Zhang, T Zhang, Y Wang… - … Medical Journal of …, 2015 - ncbi.nlm.nih.gov
Background T cell-induced inflammatory response and related cytokine secretion at the
injury site may participate in the pathogenesis of cerebral infarction. Recent studies …